Status:
COMPLETED
Long Pulse 1064 nm Nd:YAG Laser in the Treatment of Erythematotelangiectatic Rosacea and Other Erythematous Telangiectatic Facial Conditions
Lead Sponsor:
Hawler Medical University
Conditions:
Rosacea, Erythematotelangiectatic
Eligibility:
All Genders
32-52 years
Phase:
NA
Brief Summary
The goal of this clinical study is to assess the effectiveness of Nd:YAG laser 1064 nm in the long pulse mode in the treatment of signs of rosacea including the erythema of the face and telangiectasia...
Eligibility Criteria
Inclusion
- Patient with rosacea (erythemato-telangiectatic type)
Exclusion
- Other clinical types of rosacea
- Pregnancy and lactation in females
- History of malignancies
- History of photosensitivity
- History of any other modalities of treatment of rosacea over last 6 months
Key Trial Info
Start Date :
March 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 4 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06908915
Start Date
March 3 2023
End Date
November 4 2024
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hawler Medical University
Erbil, Iraq, 44001